Literature DB >> 23553799

Nano-sized CT contrast agents.

Nohyun Lee1, Seung Hong Choi, Taeghwan Hyeon.   

Abstract

Computed tomography (CT) is one of the most widely used clinical imaging modalities. In order to increase the sensitivity of CT, small iodinated compounds are used as injectable contrast agents. However, the iodinated contrast agents are excreted through the kidney and have short circulation times. This rapid renal clearance not only restricts in vivo applications that require long circulation times but also sometimes induces serious adverse effects related to the excretion pathway. In addition, the X-ray attenuation of iodine is not efficient for clinical CT that uses high-energy X-ray. Due to these limitations, nano-sized iodinated CT contrast agents have been developed that can increase the circulation time and decrease the adverse effects. In addition to iodine, nanoparticles based on heavy atoms such as gold, lanthanides, and tantalum are used as more efficient CT contrast agents. In this review, we summarize the recent progresses made in nano-sized CT contrast agents.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23553799     DOI: 10.1002/adma.201300081

Source DB:  PubMed          Journal:  Adv Mater        ISSN: 0935-9648            Impact factor:   30.849


  91 in total

Review 1.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

2.  CT Image Contrast of High-Z Elements: Phantom Imaging Studies and Clinical Implications.

Authors:  Paul F FitzGerald; Robert E Colborn; Peter M Edic; Jack W Lambert; Andrew S Torres; Peter J Bonitatibus; Benjamin M Yeh
Journal:  Radiology       Date:  2015-09-10       Impact factor: 11.105

3.  In vivo performance of gold nanoparticle-loaded absorbable inferior vena cava filters in a swine model.

Authors:  Steven Y Huang; Jossana A Damasco; Li Tian; Linfeng Lu; Joy Vanessa D Perez; Katherine A Dixon; Malea L Williams; Megan C Jacobsen; Stephen J Dria; Mitchell D Eggers; Adam D Melancon; Rick R Layman; Elizabeth M Whitley; Marites P Melancon
Journal:  Biomater Sci       Date:  2020-06-19       Impact factor: 6.843

4.  In Vivo Micro-CT Imaging of Human Mesenchymal Stem Cells Labeled with Gold-Poly-L-Lysine Nanocomplexes.

Authors:  Taeho Kim; Nohyun Lee; Dian R Arifin; Irina Shats; Miroslaw Janowski; Piotr Walczak; Taeghwan Hyeon; Jeff W M Bulte
Journal:  Adv Funct Mater       Date:  2016-11-28       Impact factor: 18.808

5.  Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance-Computed Tomography Image Guided Radiation Therapy.

Authors:  Alexandre Detappe; Eloise Thomas; Mark W Tibbitt; Sijumon Kunjachan; Oksana Zavidij; Nishita Parnandi; Elizaveta Reznichenko; François Lux; Olivier Tillement; Ross Berbeco
Journal:  Nano Lett       Date:  2017-02-02       Impact factor: 11.189

Review 6.  Preclinical imaging: an essential ally in modern biosciences.

Authors:  Lídia Cunha; Ildiko Horvath; Sara Ferreira; Joana Lemos; Pedro Costa; Domingos Vieira; Dániel S Veres; Krisztián Szigeti; Teresa Summavielle; Domokos Máthé; Luís F Metello
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 7.  Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment.

Authors:  Yunlu Dai; Can Xu; Xiaolian Sun; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2017-05-18       Impact factor: 54.564

8.  Targeted Imaging of Renal Fibrosis Using Antibody-Conjugated Gold Nanoparticles in Renal Artery Stenosis.

Authors:  Xiang-Yang Zhu; Xiangyu Zou; Rahul Mukherjee; Zhicong Yu; Christopher M Ferguson; Wei Zhou; Cynthia H McCollough; Lilach O Lerman
Journal:  Invest Radiol       Date:  2018-10       Impact factor: 6.016

9.  Wulff in a cage gold nanoparticles as contrast agents for computed tomography and photoacoustic imaging.

Authors:  Maryam Hajfathalian; Ahmad Amirshaghaghi; Pratap C Naha; Peter Chhour; Jessica C Hsu; Keely Douglas; Yuxi Dong; Chandra M Sehgal; Andrew Tsourkas; Svetlana Neretina; David P Cormode
Journal:  Nanoscale       Date:  2018-10-02       Impact factor: 7.790

Review 10.  Opportunities for new CT contrast agents to maximize the diagnostic potential of emerging spectral CT technologies.

Authors:  Benjamin M Yeh; Paul F FitzGerald; Peter M Edic; Jack W Lambert; Robert E Colborn; Michael E Marino; Paul M Evans; Jeannette C Roberts; Zhen J Wang; Margaret J Wong; Peter J Bonitatibus
Journal:  Adv Drug Deliv Rev       Date:  2016-09-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.